Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Palliative Medicine
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Toscani, F.
Right arrow Articles by Camerini, S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Toscani, F.
Right arrow Articles by Camerini, S.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Sodium naproxen: continuous subcutaneous infusion in neoplastic pain control

Franco Toscani

Sezione di Terapia del Dolore e Cure Palliative, Presidio Ospedaliero Cremonese USSL 51, Cremona

Katia Barosi

Servizio di Farmacia e Farmacologia, Presidio Ospedaliero Cremonese USSL 51, Cremona

Maurizio Scazzina

Presidio Ospedaliero Cremonese USSL 51, Cremona

Sandro Camerini

Servizio di Anestesia e Rlanimazione, Presidio Ospedaliero Cremonese USSL 51, Cremona

Fourteen patients who had been taking naproxen orally (as a single analgesic or in association with morphine, according to the therapeutic drug sequence proposed by WHO) were changed to a subcutaneous continuous infusion of sodium naproxen alone (10 cases) or associated with morphine (4 cases), administered via a portable micro-pump because of the impossibility of taking it orally. All the patients had pain from advanced cancer.

The patients were all monitored with daily checks on the severity and duration of pain, numbers of hours slept, drug use and symptom appearance. Follow-up was continued until death. The same level of analgesia achieved by oral administration was maintained for all patients. In two cases, the presence of a high sodium naproxen and morphine concentration in the same syringe produced a precipitate of morphine which caused an obstruction of the butterfly needle. The administration of sodium naproxen not combined with other drugs in the pump proved a valuable technique, well accepted by the subjects. Its effectiveness appears comparable to oral administration of naproxen.

Key Words: antiflammatory analgesics • naproxen • pain • palliative treatment • parenteral infusion • percutaneous administration

Palliative Medicine, Vol. 3, No. 3, 207-211 (1989)
DOI: 10.1177/026921638900300307
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Palliat MedHome page
V. Pace
Use of nonsteroidal anti-inflammatory drugs in cancer
Palliative Medicine, October 1, 1995; 9(4): 273 - 286.
[Abstract] [PDF]

Home page
 Palliat MedHome page
F. Toscani
Correspondence
Palliative Medicine, April 1, 1990; 4(2): 147 - 147.
[PDF]